Euractiv (Partner Content)
EU Perspectives
European Biotechnology Magazine
APM Market Access
EURACTIV - The EU must open an investigation against Washington for "unlawful coercion in national matters", Belgian Deputy Prime Minister and Health Minister Frank Vandenbroucke said on Tuesday, 6 October. Read more
EURACTIV - A decade after the first biosimilar reached European patients with rheumatoid arthritis, the evidence is in: patients do as well on the copies as on the original biologics, and a million patient-years of use confirm they are safe. Read more
EU PERSPECTIVES - A weight-loss jab bought through a social media advert can contain the wrong drug, the wrong dose, or no active ingredient at all. Fake medicines now reach Europeans through the same feeds as holiday photos. Every advert earns the platform money, and the tools to stop it already sit in EU law. Read more
EU PERSPECTIVES - New medicines mean little if patients cannot get them. EU Health Commissioner Olivér Várhelyi promised in Dublin that Europe will beat the US and China in biotech. In Gastein, drugmakers warned that patients in Europe still wait far too long. Read more
